Activists

Cloning Carl Icahn is a good idea. Now I'm of course not talking about a laboratory experiment whereby we create an army of little corporate activists that will grow into so many billionaires. Rather, I'm referring to following the renowned...

Billionaire Mori Arkin filed a 13D on Aclaris Therapeutics (ACRS), a development stage microcap biotech company with a promising treatment for common warts. Arkin bought the shares through his personal partnership, "The 1999 Company." In the activist filing he disclosed the following trades: Purchase/SaleSharesPriceDate Running ...

Starboard Value 13Ds are worth paying attention to. The hedge fund, led by manager Jeff Smith, is one of the most prolific -- and successful -- activist funds. Since 2011, Starboard has filed 305 activist reports: 47 initial 13Ds and 258 13D/A SEC...

Activist Cannell Capital raised its stake in Lee Enterprises (LEE) to 7.37%. The hedge fund filed a 13D/A on July 30 disclosing a 1.7 million additional share purchase of the newspaper publisher. Cannell is now LEE's largest shareholder. Lee Enterprises owns 49...

On March 4, Marathon Partners called ELF Beauty "undervalued" in a 13D filing with the SEC. The New York City-based hedge fund disclosed a 5.2% stake, and said in the filing it has "engaged, and plans to continue to engage, with the Issuer’s management and Board of...

Engine Capital filed a 13D on Cymabay (CBAY) two weeks after the development stage biotech company halted a trial of its leading drug candidate causing it's shares to fall as much as 75%. In a 13D filing Thursday evening, New York-based Engine Capital, L.P....

Legion Partners disclosed a 5.15% stake in Landec Corp (LNDC) after market hours on Thursday. The hedge fund stated it believes LNDC's stock price "does not reflect the Issuer’s intrinsic value." Legion believes that Landec is "engaged in an odd combination of businesses that will never achieve...

Macerich insiders have bought a record $2.8 million of the retail mall developer's stock over the last two months as Macerich (MAC) shares hit seven year lows. A great story needs a great title. And what could be better than "Retail Apocalypse" to capture...

In a 13D filed on Jan. 21 targeting Garrison Capital (GARS), corporate activist Joseph Stilwell notes that he has taken an "activist position" in 68 publicly-traded companies since 2000. In his most recent 13D, Stilwell Value, LLC disclosed a 5% stake in Garrison, a...

Hudson Executive Capital disclosed on Monday that it bought 143,200 shares of USA Technology (USAT) at $4.46 along with call options giving the fund the right to buy another 1,250,000 shares of stock at $10. The call options expire on Jan. 17, 2020.